Literature DB >> 29991431

Severe Chronic Abuse of Zolpidem in Refractory Insomnia.

Giacomo Chiaro1, Anna Castelnovo1, Giovanni Bianco1, Piermario Maffei2, Mauro Manconi1.   

Abstract

ABSTRACT: Zolpidem is an imidazopyridine nonbenzodiazepine hypnotic drug with a high affinity to the α1 subunit of the gamma amino butyric acid A receptor It is the first pharmacological option in the short-term management of sleep-onset insomnia. Initially considered a safer drug compared to benzodiazepines because of lower liability for abuse and dependence, recently, an increasing body of reports has questioned zolpidem's proneness to misuse. In this report, we describe a case of serious zolpidem abuse requiring pharmacological washout during hospitalization because of previous withdrawal seizures in a patient with chronic sleep-onset and maintenance insomnia.
© 2018 American Academy of Sleep Medicine.

Entities:  

Keywords:  abuse; actigraphy; electroencephalography; insomnia; power spectrum; video polysomnography; zolpidem

Mesh:

Substances:

Year:  2018        PMID: 29991431      PMCID: PMC6040802          DOI: 10.5664/jcsm.7240

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  28 in total

1.  Detoxification of high-dose zolpidem using cross-titration with an adequate equivalent dose of diazepam.

Authors:  Shao-Chien Chen; Hsi-Chung Chen; Shih-Cheng Liao; Mei-Chih Meg Tseng; Ming-Been Lee
Journal:  Gen Hosp Psychiatry       Date:  2011-10-28       Impact factor: 3.238

2.  Megadose bromazepam and zolpidem dependence: two case reports of treatment with flumazenil and valproate.

Authors:  Gianluca Quaglio; Marco Faccini; Caroline Victorri Vigneau; Rebecca Casari; Sophie Mathewson; Manuela Licata; Fabio Lugoboni
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

3.  Extensive craving in high dose zolpidem dependency.

Authors:  Jana Svitek; Annemarie Heberlein; Stefan Bleich; Jens Wiltfang; Johannes Kornhuber; Thomas Hillemacher
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-11-12       Impact factor: 5.067

4.  Dependence on zolpidem.

Authors:  Ming-Chyi Huang; Hong-Yen Lin; Chun-Hsin Chen
Journal:  Psychiatry Clin Neurosci       Date:  2007-04       Impact factor: 5.188

5.  Severe dependency on zolpidem in a patient with multiple sclerosis suffering from paraspasticity.

Authors:  Julia Damm; Daniela Eser; Hans-Juergen Moeller; Rainer Rupprecht
Journal:  World J Biol Psychiatry       Date:  2010-03       Impact factor: 4.132

Review 6.  Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.

Authors:  G Hajak; W E Müller; H U Wittchen; D Pittrow; W Kirch
Journal:  Addiction       Date:  2003-10       Impact factor: 6.526

7.  Intravenous zolpidem injection in a zolpidem abuser.

Authors:  W-Y Hsu; N-Y Chiu
Journal:  Pharmacopsychiatry       Date:  2012-10-23       Impact factor: 5.788

8.  The abuse potential of zolpidem administered alone and with alcohol.

Authors:  C J Wilkinson
Journal:  Pharmacol Biochem Behav       Date:  1998-05       Impact factor: 3.533

9.  A postmarketing study of relative abuse liability of hypnotic sedative drugs.

Authors:  Jerome H Jaffe; Roger Bloor; Ilana Crome; Malcolm Carr; Farrukh Alam; Arnol Simmons; Roger E Meyer
Journal:  Addiction       Date:  2004-02       Impact factor: 6.526

10.  Zolpidem dependence, abuse and withdrawal: A case report.

Authors:  Mostafa Heydari; Mohsen Saberi Isfeedvajani
Journal:  J Res Med Sci       Date:  2013-11       Impact factor: 1.852

View more
  8 in total

1.  Consequences of the new zolpidem prescription regulations: a cohort study from the French national healthcare database.

Authors:  J Touchard; P Sabatier; G Airagnes; S Berdot; B Sabatier
Journal:  Eur J Clin Pharmacol       Date:  2019-10-13       Impact factor: 2.953

Review 2.  Zolpidem: Efficacy and Side Effects for Insomnia.

Authors:  Amber N Edinoff; Natalie Wu; Yahya T Ghaffar; Rosemary Prejean; Rachel Gremillion; Mark Cogburn; Azem A Chami; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2021-06-18

3.  An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Int J Neuropsychopharmacol       Date:  2019-04-01       Impact factor: 5.176

4.  'Z-trip'? A Comprehensive Overview and a Case-series of Zolpidem Misuse.

Authors:  Laura Orsolini; Stefania Chiappini; Paolo Grandinetti; Angelo Bruschi; Roberta Testa; Alessandra Provenzano; Domenico De Berardis; Umberto Volpe
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-05-31       Impact factor: 2.582

5.  Zolpidem withdrawal seizure in an Iranian young woman: A case presentation.

Authors:  Pezhman Hadinezhad; Seyed Hamzeh Hosseini
Journal:  Caspian J Intern Med       Date:  2021

6.  Regulatory Framework Implementation for the Prescription of Zolpidem in France, What Impact in the Older People?

Authors:  Alexandra Jobert; Marion Istvan; Edouard-Jules Laforgue; Benoit Schreck; Caroline Victorri-Vigneau
Journal:  Int J Environ Res Public Health       Date:  2021-11-18       Impact factor: 3.390

7.  Case report: Chronological symptom profile after cessation of overdose zolpidem in a patient with comorbid bipolar disorder-from anxiety, craving, paresthesia and influenza-like symptoms to seizures and hallucinations.

Authors:  Zi-Xin Mao; Xia Yang; Hui-Yao Wang; Wan-Jun Guo
Journal:  Front Psychiatry       Date:  2022-08-17       Impact factor: 5.435

Review 8.  The Management and Alternative Therapies for Comorbid Sleep Disorders in Epilepsy.

Authors:  Weifeng Peng; Jing Ding; Xin Wang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.